Parabilis Medicines Statistics
Total Valuation
PBLS has a market cap or net worth of $4.07 billion. The enterprise value is $3.79 billion.
| Market Cap | 4.07B |
| Enterprise Value | 3.79B |
Important Dates
The next estimated earnings date is Tuesday, August 18, 2026, before market open.
| Earnings Date | Aug 18, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PBLS has 127.34 million shares outstanding.
| Current Share Class | 125.76M |
| Shares Outstanding | 127.34M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +1.61% |
| Owned by Insiders (%) | 0.09% |
| Owned by Institutions (%) | 29.91% |
| Float | 96.46M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 162.79 |
| PB Ratio | 16.66 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.12, with a Debt / Equity ratio of 0.22.
| Current Ratio | 6.12 |
| Quick Ratio | 6.07 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -107.48 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -46.09% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.45M |
| Employee Count | 145 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 54.66 |
| Average Volume (20 Days) | 454,819 |
Short Selling Information
The latest short interest is 3.95 million, so 3.11% of the outstanding shares have been sold short.
| Short Interest | 3.95M |
| Short Previous Month | 2.77M |
| Short % of Shares Out | 3.11% |
| Short % of Float | 4.10% |
| Short Ratio (days to cover) | 4.91 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -156.12M |
| Pretax Income | -152.88M |
| Net Income | -209.71M |
| EBITDA | -149.58M |
| EBIT | -152.08M |
| Earnings Per Share (EPS) | -$67.09 |
Balance Sheet
The company has $329.04 million in cash and $53.15 million in debt, with a net cash position of $275.89 million or $2.17 per share.
| Cash & Cash Equivalents | 329.04M |
| Total Debt | 53.15M |
| Net Cash | 275.89M |
| Net Cash Per Share | $2.17 |
| Equity (Book Value) | 244.22M |
| Book Value Per Share | -174.15 |
| Working Capital | 277.83M |
Cash Flow
In the last 12 months, operating cash flow was -$138.76 million and capital expenditures -$601,000, giving a free cash flow of -$139.36 million.
| Operating Cash Flow | -138.76M |
| Capital Expenditures | -601,000 |
| Depreciation & Amortization | 2.45M |
| Net Borrowing | -6.85M |
| Free Cash Flow | -139.36M |
| FCF Per Share | -$1.09 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PBLS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -5.15% |
| FCF Yield | -3.42% |
Analyst Forecast
The average price target for PBLS is $41.75, which is 30.63% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $41.75 |
| Price Target Difference | 30.63% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |